Whalen Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.16M Buy
2,353
+524
+29% +$531K 1.16% 19
2025
Q4
$1.97M Sell
1,829
-722
-28% -$690K 1.06% 20
2025
Q3
$1.95M Buy
2,551
+2,254
+759% +$1.68M 1.14% 20
2025
Q2
$231K Buy
297
+13
+5% +$10.1K 0.15% 185
2025
Q1
$234K Sell
284
-740
-72% -$616K 0.16% 112
2024
Q4
$790K Sell
1,024
-398
-28% -$330K 0.55% 35
2024
Q3
$1.26M Sell
1,422
-55
-4% -$49.4K 0.89% 23
2024
Q2
$1.34M Sell
1,477
-247
-14% -$198K 1.06% 20
2024
Q1
$1.34M Sell
1,724
-18
-1% -$12.8K 0.99% 18
2023
Q4
$1.02M Buy
+1,742
New +$1.02M 0.91% 26

Other funds holding LLY

Whalen Wealth Management's LLY Position: Q1 2026 in Review

Whalen Wealth Management increased its Eli Lilly (LLY) stake by 29% in Q1 2026, buying an estimated $531K and bringing the position to 2,353 shares worth $2.16M. The position accounts for 1.16% of the portfolio, ranked #19.

Whalen Wealth Management first reported a position in LLY in Q4 2023 and has held it in 10 quarters since. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Whalen Wealth Management held 2,353 shares of Eli Lilly worth $2.16M as of Q1 2026.
  • Whalen Wealth Management bought 524 Eli Lilly shares in Q1 2026, an estimated $531K.
  • Eli Lilly made up 1.16% of Whalen Wealth Management's portfolio in Q1 2026, its #19 holding.
  • Whalen Wealth Management first reported a position in Eli Lilly in Q4 2023 and has held it in 10 quarters since.
  • 4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Whalen Wealth Management's 13F filing for Q1 2026, filed 13 Apr 2026.